DPCP for the treatment of alopecia areata.
Skin Therapy Lett. 2000; 5(5):3-4.ST

Abstract

Topical immunotherapy with diphencyprone (DPCP) for the treatment of severe alopecia areata has been used since 1983 and is felt to be the treatment of choice by many dermatologists. Although there have been no major side effects reported since its initial use, there remain some unknowns regarding its safety. Because DPCP has at least a 40% success rate for cosmetically acceptable regrowth in extensive alopecia areata, its availability is an important matter for patients with alopecia areata.

Authors+Show Affiliations

Bolduc C

Division of Dermatology, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

Shapiro J

No affiliation info available

MeSH

Administration, TopicalAlopecia AreataCyclopropanesHairHumansImmunotherapy

Pub Type(s)

Journal Article

Language

eng

PubMed ID

10854342

Citation

Bolduc, C, and J Shapiro. "DPCP for the Treatment of Alopecia Areata." Skin Therapy Letter, vol. 5, no. 5, 2000, pp. 3-4.

Bolduc C, Shapiro J. DPCP for the treatment of alopecia areata. Skin Therapy Lett. 2000;5(5):3-4.

Bolduc, C., & Shapiro, J. (2000). DPCP for the treatment of alopecia areata. Skin Therapy Letter, 5(5), 3-4.

Bolduc C, Shapiro J. DPCP for the Treatment of Alopecia Areata. Skin Therapy Lett. 2000;5(5):3-4. PubMed PMID: 10854342.

* Article titles in AMA citation format should be in sentence-case

TY - JOUR T1 - DPCP for the treatment of alopecia areata. AU - Bolduc,C, AU - Shapiro,J, PY - 2000/6/15/pubmed PY - 2000/9/2/medline PY - 2000/6/15/entrez SP - 3 EP - 4 JF - Skin therapy letter JO - Skin Therapy Lett VL - 5 IS - 5 N2 - Topical immunotherapy with diphencyprone (DPCP) for the treatment of severe alopecia areata has been used since 1983 and is felt to be the treatment of choice by many dermatologists. Although there have been no major side effects reported since its initial use, there remain some unknowns regarding its safety. Because DPCP has at least a 40% success rate for cosmetically acceptable regrowth in extensive alopecia areata, its availability is an important matter for patients with alopecia areata. SN - 1201-5989 UR - https://www.unboundmedicine.com/medline/citation/10854342/DPCP_for_the_treatment_of_alopecia_areata_ L2 - http://www.diseaseinfosearch.org/result/313 DB - PRIME DP - Unbound Medicine ER -

Tags

DPCP for the treatment of alopecia areata.Skin Therapy Lett. 2000; 5(5):3-4.ST